Skip to main content
logo
Arecor Therapeutics plc (AIM:AREC)
London flag London · Delayed Price · Currency is GBP · Price in GBX
63.27
-2.73 (-4.14%)
Apr 15, 2026, 3:43 PM GMT

Arecor Therapeutics Revenue

In the year 2025, Arecor Therapeutics had annual revenue of 1.71M GBP, down -66.08%. Arecor Therapeutics had revenue of 2.00M in the half year ending June 30, 2025, with 20.01% growth.

Revenue
1.71M
Revenue Growth
-66.08%
P/S Ratio
14.54
Revenue / Employee
38.95K
Employees
44
Market Cap
24.92M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.71M-3.34M-66.08%
Dec 31, 20245.05M480.00K10.50%
Dec 31, 20234.57M2.17M90.30%
Dec 31, 20222.40M1.25M107.51%
Dec 31, 20211.16M-540.00K-31.80%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
hVIVO54.47M
SkinBioTherapeutics4.64M
Fusion Antibodies1.60M
Aptamer Group1.38M
Ondine Biomedical1.18M
Faron Pharmaceuticals Oy1.14M
ImmuPharma-69.96K
Revenue Rankings

Arecor Therapeutics News

More News